05233429 · Active · incorporated 21 years, 10 months ago · Southampton
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series B+
Synairgen is a biotechnology company focused on the discovery and development of treatments for severe respiratory diseases, including their lead drug candidate SNG001.
See the complete cap table with every shareholder, founder tags, dilution across 13 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.